Latest News & Features
article
As states “legalise recreational use” of cannabis, firms are strengthening their IP offering in the industry | Expert cannabis attorney adds to Greenspoon Marder’s services in the market. 21 July 2023
Copyright
Russia’s acquisition of Danone and Carlsberg units is a complex scenario that shows how brand owners should be wary of taking chances when it comes to safeguarding their IP, says Agnieszka Sztoldman of the University of Wroclaw and Osborne Clarke. 21 July 2023
article
Computer scientist and patent attorney joins the car maker as it embarks on a shift towards a lifestyle brand | AI expert spent more than 20 years at the tech company. 20 July 2023
Patents
Plaintiff has sued Google, Cisco, IBM and numerous others over alleged infringement | Latest suit concerns a security patent that Nokia, Samsung and others have also been accused of infringing. 20 July 2023
Copyright
In a recent webinar, the US Copyright Office clarified when applicants need to disclose AI contributions to their work, say Mark Doerr and Alexis Marin of Greenspoon Marder. 20 July 2023
Global Trade Secrets
Case highlights “conflict that is more likely to occur as law firms get bigger” | Multinational compared to “a seasoned vaudeville actor” that was reasonably informed | Disqualification of counsel “extraordinary remedy” that should be used sparingly. 19 July 2023
Global Trade Secrets
New hire has 30 years of public and private sector experience | Washington, DC litigator will be ‘invaluable to our clients navigating business-critical enforcement and litigation matters’. 19 July 2023
Copyright
Discussion will explore the need for effective AI rules in light of risks | UK government’s IP plans may be scrutinised | HoL publishes key report on country’s AI strategy. 19 July 2023
Patents
The Act has hopes to make much-needed reforms to the ITC and protect it from ‘persistent abuse’ by patent ‘trolls’. But critics say it’s too one-sided, finds Sarah Speight. 18 July 2023
Patents
Side letter to CPTPP agreement allows UK to opt-out of grace period for patents | No new action required on pharmaceutical patents or GIs. 18 July 2023
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.